Rzepień pospolity ( Xanthium strumarium L.) – analiza fitochemiczna steroli i triterpenów

1. Wolski T. i wsp.: Rzepień pospolity ( Xanthium strumarium L.) surowiec zielarski, o wielokierunkowym działaniu farmakologicznym – analiza fitochemiczna związków fenolowych. Post. Fitoter. 2006, 3, 118. 2. Mannan S.C. Ahmad K.: Preliminary study of sex hormone of medical importance in Bangladesh plants. Bangladesh Med. Res. Coun. Bull. 1978, 4, 78. 3. Kapoor V.K. i wsp.: Studies on the oil of Xanthium strumarium L. J. Am. Oil Chem. Soc. 1976, 53, 524. 4. Khafagy S.M. i wsp.: Phytochemical investigation of Xanthium strumarium.Planta Med. 1974, 26, 75. 5. Khafagy S.M., Metwally A.M.: Isolation of a crystalline sesquiterpenic keto-lactone from Xanthium occidentale.Planta Med. 1970, 18, 318. 6. Ziętek E.: Analiza steroli i triterpenów w częściach podziemnych i nadziemnych Xanthium strumarium L. Praca magisterska AM Lublin 2005. 7. Strzelecka H., Kowalski J.: Encyklopedia zielarstwa i ziołolecznictwa. PWN, Warszawa 2000, 645. 8. Otałęga Z. (red.): Encyklopedia biologiczna. OPRES, Kraków. 1999, t.10, 142, 414. 9. Kohlmünzer S.: Farmakognozja. Podręcznik dla studentów farmacji. PZWL, Warszawa 2000, 309, 341. 10. Różański H.: Naturalne substancje anaboliczne. http://luskiewnik.strefa.pl/fitosterole/sterole/pages/p6.htm. 11. Kączkowski J.: Biochemia roślin. T.1 PWN, Warszawa 1987. 12. Van den Heuvel M.R i wsp.: Assessment of the reproductive-endocrine disrupting potential of chlorine dioxide oxidation products of plant sterols. Environ. Sci. Technol. 2006, 40, 2594. 13. Krygier K.: Fitosterole – istotny czynnik obniżający poziom cholesterolu we krwi. Przem. Spoż. 2002, 56, 18. 14. Lees A.M. i wsp: Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 1977, 28, 325. 15. Hendriks H.F. i wsp.: Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 1999, 53, 319. 16. Hamada T. i wsp.: Solubility in and affinity for the bile salt micelle of plant sterols are important determinants of their intestinal absorption in rats. Lipids 2006, 41, 551. 17. Ostlund R.E. i wsp.: Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans. Am. J. Clin. Nutr. 1999, 70, 826. 18. Hallikainen M.A. i wsp.: Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur. J. Clin. Nutr. 2000, 54, 715. 19. Thomsen A.B. i wsp.: Effect of free plant sterols in low-fat milk on serum lipid profile in hypercholesterolemic subjects. Eur. J. Clin. Nutr. 2004, 58, 860. 20. Plat J. i wsp.: Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J. Lipid. Res. 2005, 46, 2468. 21. Berger A. i wsp.: Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis. 2004, 3, 5. 22. Devaraj S., Jialal I.: The role of dietary supplementation with plant sterols and stanols in the prevention of cardiovascular disease. Nutr. Rev. 2006, 64, 348. 23. Moghadasian M.H. i wsp.: Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action. Circulation 1999, 99, 1733. 24. Ntanios F.Y. i wsp.: Dietary sitostanol reduces plaque formation but not lecithin cholesterol acyl transferase activity in rabbits. Atherosclerosis 1998, 138, 101. 25. Business Wire. http://www.businesswire.com/cgi-bin/photo.cgi?pw.020502/bb9. 26. Bouic P.J.: The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Curr. Opin. Clin. Nutr. Metab. Care 2001, 4, 471. 27. Bouic P.J. i wsp.: Plant sterol/sterolin supplement use in a cohort of South African HIV-infected patients – effects on immunological and virological surrogate markers. S. Afr. Med. J. 2001, 91, 848. 28. Awad A.B., Fink C.S.: Phytosterols as anticancer dietary components: evidence and mechanism of action. J. Nutr. 2000, 130, 2127. 29. Awad A.B. i wsp.: Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res. 2000, 20, 821. 30. Normén A.L. i wsp.: Plant sterol intakes and colorectal cancer risk in the Netherlands Cohort Study on Diet and Cancer. Am. J. Clin. Nutr. 2001, 74, 141. 31. Mendilaharsu M. i wsp.: Phytosterols and risk of lung cancer: A case-control study in Uruguay. Lung Cancer 1998, 21, 37. 32. De Stefani E. i wsp.: Vegetables, fruits, related dietary antioxidants, and risk of squamous cell carcinoma of the esophagus: A case-control study in Uruguay. Nutr. Cancer 2000, 38, 23. 33. McCann S.E. i wsp.: Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control 2000, 11, 965. 34. Awad A.B. i wsp.: Effect of β-sitosterol, a plant sterol, on growth, protein phosphatase 2A, and phospholipase D in LNCaP cells. Nutr. Cancer. 2000, 36, 74. 35. Wang T. i wsp.: Antioxidant activity of phytosterols, oryzanol, and other phytosterol conjugates. J. Am. Oil. Chem. Soc. 2002, 79, 1201. 36. Van Rensburg S.J. i wsp.: A comparative study of the effects of cholesterol, β-sitosterol, β-sitosterol glucoside, dehydroepiandrosterone sulphate and melatonin on in vitro lipid peroxidation. Metab. Brain. Dis. 2000, 15, 257. 37. Loscalzo J: Oxidant stress: A key determinant of atherothrombosis. Biochem. Soc. Trans. 2003, 31, 1059. 38. Paul Jayaraj A. i wsp.: Duodenal ulcer prevalence: Research into the nature of possible protective dietary lipids. Phytother. Res. 2003, 17, 391. 39. Della Loggia R. i wsp.: The role of triterpenoids in the topical anti-inflamatory activity of Calendula officinalis flowers. Planta Med. 1994, 60, 516. 40. De Miranda A.L. i wsp.: Anti-inflammatory and analgesic activities of the latex containing triterpenes from Himatanthus sucuuba. Planta Med. 2000, 66, 284. 41. Mahato S.B. i wsp.: Triterpenoids. Phytochemistry 1992, 31, 2199. 42. Recio M.C. i wsp.: Investigation on the steroidal anti-inflamatory activity of triterpenoids from Diospyros leucomelas. Planta Med. 1995, 61, 9. 43. Recio M.C. i wsp.: Structural requirement for the anti-inflammatory activity of antural triterpenoids. Planta Med. 1995, 61, 182. 44. Ryo S.Y. i wsp.: Anti-allergic and anti-inflammatory triterpenoids from the herb of Prunella vulgaris. Planta Med. 2000, 66, 358. 45. Fulda S. i wsp.: Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer. 1999, 82, 435. 46. Fulda S. i wsp.: Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 1997, 57, 4956. 47. Hostanska K. i wsp.: Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol. Pharm. Bull. 2004, 27, 1970. 48. Cioffi G. i wsp.: Antiproliferative triterpene saponins from Entada africana. J. Nat. Prod. 2006, 69, 1323. 49. Kashiwada Y. i wsp.: 3-O-Glutaryl-dihydrobetulin and related monoacyl derivatives as potent anti-HIV agents. Bioorg. Med. Chem. Lett. 2004, 14, 5851. 50. Kashiwada Y. i wsp.: Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J. Nat. Prod. 1998, 61, 1090. 51. Fujioka T. i wsp.: Anti-AIDS agents. 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 1994, 57, 243. 52. Konig G.M. i wsp.: Assessment of anti-micobacterial activity of a series of mainly marine derived natural products. Planta Med. 2000, 66, 337. 53. Schuhly W. i wsp.: New triterpenoids with anti-bacterial activity from Zizyphus joazeiro. Planta Med. 1999, 65, 740. 54. Sudhahar V. i wsp.: Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Life Sci. 2006, 78, 1329. 55. Yoshikawa M. i wsp.: Floratheasaponins A-C, acylated oleanane-type triterpene oligoglycosides with anti-hyperlipidemic activities from flowers of the tea plant ( Camellia sinensis). J. Nat. Prod. 2005, 68, 1360. 56. Chen H.W. i wsp.: Effect of alisol B acetate, a plant triterpene, on apoptosis in vascular smooth muscle cells and lymphocytes. Eur. J. Pharmacology 2001, 419, 127. 57. Jerzmanowska Z.: Substancje roślinne – metody wyodrębniania. PWN, Warszawa 1970. 58. Ostrowski W., Filipowicz B.: Ćwiczenia z chemii ogólnej i fizjologicznej. PWRiL, Warszawa 1954. 59. NIST/EPA/NIH: Mas Spectral Library. USA 2002. 60. Finningan MAT. Terpene Library, Finningan: Electronic database. USA 1990. 61. Joulain D., König W.A.: The atlas of spectral data of sesquiterpene hydrocarbons. E.B. Verlag. Hamburg 1998. 62. Kołodziejczyk A. Naturalne związki organiczne. PWN, Warszawa 2003, 427. 63. Kopcewicz J., Lewak S. (red): Fizjologia roślin. PWN, Warszawa 2005, 369.